In a Sept. 18 report, Roth Capital Markets analyst Boobalan Pachaiyappan reiterated a “Buy” rating and US$10.00 target on Cingulate (Cingulate Stock Quote, Chart, News, Analysts, Financials NASDAQ:CING), citing progress toward commercialization of its lead ADHD therapy CTx-1301 and the company’s strengthened supply chain. On Sept. 17, Cingulate announced an exclusive manufacturing partnership with Bend […]
In a Sept. 17 report, Haywood Capital Markets analyst Gianluca Tucci said a new memorandum of understanding signed by MineHub Technologies (MineHub Technologies Stock Quote, Chart, News, Analysts, Financials TSXV:MHUB) marks a significant strategic expansion beyond its core base metals platform into the iron ore market. “The iron ore partnership is a strong signal of […]
Share
Tweet
Share
